Antisense oligodeoxynucleotides as clinical therapeutic agents.
about
Characterization and mapping of the double-stranded regions involved in activation of PKR within a cellular RNA from 3T3-F442A cellsThe quest for an efficacious antiviral for respiratory syncytial virus.Gene modulation for treating liver fibrosisAnomeric inversion (from beta to alpha) in methylphosphonate oligonucleosides enhances their affinity for DNA and RNA.Development of targeted delivery systems for nucleic acid drugs.Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
P2860
Q34630940-DA660276-C469-41FB-9A90-A01500A9425FQ35115949-BC78F860-3DAB-4440-9824-C27371B51E8BQ36921638-C4FFBF20-4373-483E-ABED-7A05D069AA52Q38332968-8DD253B4-0238-4B15-B708-D93DFE5D3EF0Q38349807-6A547CA7-5094-4084-97DE-394D7AF2FEE7Q40770171-1B2A2050-E998-4041-A18F-71C70162C30AQ41014533-B909537F-D5B1-4108-8A03-19930921BE64
P2860
Antisense oligodeoxynucleotides as clinical therapeutic agents.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Antisense oligodeoxynucleotides as clinical therapeutic agents.
@en
type
label
Antisense oligodeoxynucleotides as clinical therapeutic agents.
@en
prefLabel
Antisense oligodeoxynucleotides as clinical therapeutic agents.
@en
P2860
P1433
P1476
Antisense oligodeoxynucleotides as clinical therapeutic agents.
@en
P2093
Tonkinson JL
P2860
P356
10.3109/07357909609018436
P577
1996-01-01T00:00:00Z